Screener
Ligand Pharmaceuticals LGND Stock-Based Comp
Stock-Based Comp at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Total revenues and income | $63,693 | $47,627 | $115,415 | $92,960 |
| Share-based compensation | (13,653) | (9,997) | (24,249) | (17,833) |
| Other segment items: | ||||
| Amortization of intangibles | (8,097) | (8,258) | (16,194) | (16,515) |
| Depreciation of property and equipment | (118) | (264) | (237) | (777) |
| Interest income | 7,298 | 1,621 | 13,953 | 3,392 |
| Interest expense | (1,748) | (1,153) | (3,495) | (2,020) |
| Other * | 1,133 | (24,729) | (50,030) | (96,811) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Ligand Pharmaceuticals's stock-based comp?
- Ligand Pharmaceuticals (LGND) reported stock-based comp of $13.65M in Q2 2026.
- How has Ligand Pharmaceuticals's stock-based comp changed year-over-year?
- Ligand Pharmaceuticals's stock-based comp increased by 36.6% year-over-year, from $10M to $13.65M.
- What is the long-term trend for Ligand Pharmaceuticals's stock-based comp?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's stock-based comp has grown at a 4.8% compound annual growth rate (CAGR), from $38.78M to $46.85M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Ligand Pharmaceuticals's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude